Back

Dilated cardiomyopathy with severe left ventricular dysfunction and right atrial thrombi secondary to thyrotoxicosis.

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Clinical Cases - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Saoussen Antit

Interior Security Forces Hospital, Tunis (Tunisia)

6 More presentations in this session

Presentation thumbnail
Anagrelide induced cardiomyopathy: a case report
Doctor A. Tsipis (Athens, GR)
Abstract
Presentation thumbnail
Use of sacubitril/valsartan beyond guidelines
Doctor H. Altay (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Questions and doubts about ARNI therapy in a patient with heart failure: a real life experience
Mr D. Kosuta (Ljubljana, SI)
Abstract
Presentation thumbnail
Case 5-Fluorouacil-Induced Myocardial Infarction and Recurrent Stent Thrombosis; An Unusual Case
Doctor B. Lefebvre (Montreal, CA)
Abstract Slides
Presentation thumbnail
The legend of a stone heart
Doctor M. Rusu (Buzau, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Clinical Cases - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources